Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-13-288747
Filing Date
2013-07-12
Accepted
2013-07-12 06:09:52
Documents
7
Effectiveness Date
2013-07-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d563877ddefa14a.htm DEFA14A 55184
2 GRAPHIC g563877g09z47.jpg GRAPHIC 9824
3 GRAPHIC g563877g28i09.jpg GRAPHIC 17599
4 GRAPHIC g563877g44y00.jpg GRAPHIC 9860
5 GRAPHIC g563877g48r25.jpg GRAPHIC 9835
6 GRAPHIC g563877g78w23.jpg GRAPHIC 14339
7 GRAPHIC g563877g84a94.jpg GRAPHIC 9858
  Complete submission text file 0001193125-13-288747.txt   155649
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-00100 | Film No.: 13964966
SIC: 2834 Pharmaceutical Preparations